Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2023 | Lenvatinib Compared with Sorafenib as a First-Line Treatment for Radioactive Iodine-Refractory, Progressive, Differentiated Thyroid Carcinoma: Real-World Outcomes in a Multicenter Retrospective Cohort Study | THYROID |